US Patent Issued on July 14 for "Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (SARS)" (German Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,681,017, issued on July 14.

"Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (SARS)" was invented by Stefan Ebmeyer (Hoppegarten, Germany), Manne Krop (Berlin) and Jutta Odarjuk (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a method for prognosing disease progression in a patient that has or is at risk of developing a severe acute respiratory syndrome (SARS), wherein the method comprises determining a level of pro-adrenomedullin (proADM) or fragment(s) thereof in a sample from the patient, wherein said level indicates the severity of SARS progression. The method is in some embo...